img

Global G6PD Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global G6PD Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

G6PD Antibody (G-12) is an IgG1 κ mouse monoclonal G6PD antibody (also designated Glucose-6-Phosphate 1-Dehydrogenase antibody, or G6PD1 antibody) that detects the G6PD protein of human origin by WB, IP, IF, IHC(P) and ELISA.
G6PD Antibody report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global G6PD Antibody market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Immunochemistry (IHC) and Immunofluorescence (IF) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for G6PD Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, G6PD Antibody key companies include Merck, IBL, GeneTex, Aviva Systems Biology, LifeSpan BioSciences, RayBiotech, NSJ Bioreagents, ProSci and Abnova Corporation, etc. Merck, IBL, GeneTex are top 3 players and held % share in total in 2022.
G6PD Antibody can be divided into Monoclonal and Polyclonal, etc. Monoclonal is the mainstream product in the market, accounting for % share globally in 2022.
G6PD Antibody is widely used in various fields, such as Immunochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP) and Western Blot (WB), etc. Immunochemistry (IHC) provides greatest supports to the G6PD Antibody industry development. In 2022, global % share of G6PD Antibody went into Immunochemistry (IHC) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global G6PD Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck
IBL
GeneTex
Aviva Systems Biology
LifeSpan BioSciences
RayBiotech
NSJ Bioreagents
ProSci
Abnova Corporation
Bethyl Laboratories
Cell Signaling Technology
Leading Biology
Thermo Fisher Scientific
OriGene Technologies
ABclonal Technology
Proteintech Group
Sino Biological
Abcam
United States Biological
Biobyt
Jingjie PTM BioLab
Wuhan Fine
Segment by Type
Monoclonal
Polyclonal

Segment by Application


Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the G6PD Antibody market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, G6PD Antibody introduction, etc. G6PD Antibody Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of G6PD Antibody market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of G6PD Antibody
1.1 G6PD Antibody Market Overview
1.1.1 G6PD Antibody Product Scope
1.1.2 G6PD Antibody Market Status and Outlook
1.2 Global G6PD Antibody Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global G6PD Antibody Market Size by Region (2018-2033)
1.4 Global G6PD Antibody Historic Market Size by Region (2018-2023)
1.5 Global G6PD Antibody Market Size Forecast by Region (2024-2033)
1.6 Key Regions, G6PD Antibody Market Size (2018-2033)
1.6.1 North America G6PD Antibody Market Size (2018-2033)
1.6.2 Europe G6PD Antibody Market Size (2018-2033)
1.6.3 Asia-Pacific G6PD Antibody Market Size (2018-2033)
1.6.4 Latin America G6PD Antibody Market Size (2018-2033)
1.6.5 Middle East & Africa G6PD Antibody Market Size (2018-2033)
2 G6PD Antibody Market by Type
2.1 Introduction
2.1.1 Monoclonal
2.1.2 Polyclonal
2.2 Global G6PD Antibody Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global G6PD Antibody Historic Market Size by Type (2018-2023)
2.2.2 Global G6PD Antibody Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America G6PD Antibody Revenue Breakdown by Type (2018-2033)
2.3.2 Europe G6PD Antibody Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific G6PD Antibody Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America G6PD Antibody Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa G6PD Antibody Revenue Breakdown by Type (2018-2033)
3 G6PD Antibody Market Overview by Application
3.1 Introduction
3.1.1 Immunochemistry (IHC)
3.1.2 Immunofluorescence (IF)
3.1.3 Immunoprecipitation (IP)
3.1.4 Western Blot (WB)
3.1.5 ELISA
3.1.6 Others
3.2 Global G6PD Antibody Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global G6PD Antibody Historic Market Size by Application (2018-2023)
3.2.2 Global G6PD Antibody Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America G6PD Antibody Revenue Breakdown by Application (2018-2033)
3.3.2 Europe G6PD Antibody Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific G6PD Antibody Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America G6PD Antibody Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa G6PD Antibody Revenue Breakdown by Application (2018-2033)
4 G6PD Antibody Competition Analysis by Players
4.1 Global G6PD Antibody Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in G6PD Antibody as of 2022)
4.3 Date of Key Players Enter into G6PD Antibody Market
4.4 Global Top Players G6PD Antibody Headquarters and Area Served
4.5 Key Players G6PD Antibody Product Solution and Service
4.6 Competitive Status
4.6.1 G6PD Antibody Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck G6PD Antibody Products, Services and Solutions
5.1.4 Merck G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 IBL
5.2.1 IBL Profile
5.2.2 IBL Main Business
5.2.3 IBL G6PD Antibody Products, Services and Solutions
5.2.4 IBL G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.2.5 IBL Recent Developments
5.3 GeneTex
5.3.1 GeneTex Profile
5.3.2 GeneTex Main Business
5.3.3 GeneTex G6PD Antibody Products, Services and Solutions
5.3.4 GeneTex G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.3.5 Aviva Systems Biology Recent Developments
5.4 Aviva Systems Biology
5.4.1 Aviva Systems Biology Profile
5.4.2 Aviva Systems Biology Main Business
5.4.3 Aviva Systems Biology G6PD Antibody Products, Services and Solutions
5.4.4 Aviva Systems Biology G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.4.5 Aviva Systems Biology Recent Developments
5.5 LifeSpan BioSciences
5.5.1 LifeSpan BioSciences Profile
5.5.2 LifeSpan BioSciences Main Business
5.5.3 LifeSpan BioSciences G6PD Antibody Products, Services and Solutions
5.5.4 LifeSpan BioSciences G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.5.5 LifeSpan BioSciences Recent Developments
5.6 RayBiotech
5.6.1 RayBiotech Profile
5.6.2 RayBiotech Main Business
5.6.3 RayBiotech G6PD Antibody Products, Services and Solutions
5.6.4 RayBiotech G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.6.5 RayBiotech Recent Developments
5.7 NSJ Bioreagents
5.7.1 NSJ Bioreagents Profile
5.7.2 NSJ Bioreagents Main Business
5.7.3 NSJ Bioreagents G6PD Antibody Products, Services and Solutions
5.7.4 NSJ Bioreagents G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.7.5 NSJ Bioreagents Recent Developments
5.8 ProSci
5.8.1 ProSci Profile
5.8.2 ProSci Main Business
5.8.3 ProSci G6PD Antibody Products, Services and Solutions
5.8.4 ProSci G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.8.5 ProSci Recent Developments
5.9 Abnova Corporation
5.9.1 Abnova Corporation Profile
5.9.2 Abnova Corporation Main Business
5.9.3 Abnova Corporation G6PD Antibody Products, Services and Solutions
5.9.4 Abnova Corporation G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.9.5 Abnova Corporation Recent Developments
5.10 Bethyl Laboratories
5.10.1 Bethyl Laboratories Profile
5.10.2 Bethyl Laboratories Main Business
5.10.3 Bethyl Laboratories G6PD Antibody Products, Services and Solutions
5.10.4 Bethyl Laboratories G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.10.5 Bethyl Laboratories Recent Developments
5.11 Cell Signaling Technology
5.11.1 Cell Signaling Technology Profile
5.11.2 Cell Signaling Technology Main Business
5.11.3 Cell Signaling Technology G6PD Antibody Products, Services and Solutions
5.11.4 Cell Signaling Technology G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.11.5 Cell Signaling Technology Recent Developments
5.12 Leading Biology
5.12.1 Leading Biology Profile
5.12.2 Leading Biology Main Business
5.12.3 Leading Biology G6PD Antibody Products, Services and Solutions
5.12.4 Leading Biology G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.12.5 Leading Biology Recent Developments
5.13 Thermo Fisher Scientific
5.13.1 Thermo Fisher Scientific Profile
5.13.2 Thermo Fisher Scientific Main Business
5.13.3 Thermo Fisher Scientific G6PD Antibody Products, Services and Solutions
5.13.4 Thermo Fisher Scientific G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.13.5 Thermo Fisher Scientific Recent Developments
5.14 OriGene Technologies
5.14.1 OriGene Technologies Profile
5.14.2 OriGene Technologies Main Business
5.14.3 OriGene Technologies G6PD Antibody Products, Services and Solutions
5.14.4 OriGene Technologies G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.14.5 OriGene Technologies Recent Developments
5.15 ABclonal Technology
5.15.1 ABclonal Technology Profile
5.15.2 ABclonal Technology Main Business
5.15.3 ABclonal Technology G6PD Antibody Products, Services and Solutions
5.15.4 ABclonal Technology G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.15.5 ABclonal Technology Recent Developments
5.16 Proteintech Group
5.16.1 Proteintech Group Profile
5.16.2 Proteintech Group Main Business
5.16.3 Proteintech Group G6PD Antibody Products, Services and Solutions
5.16.4 Proteintech Group G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.16.5 Proteintech Group Recent Developments
5.17 Sino Biological
5.17.1 Sino Biological Profile
5.17.2 Sino Biological Main Business
5.17.3 Sino Biological G6PD Antibody Products, Services and Solutions
5.17.4 Sino Biological G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.17.5 Sino Biological Recent Developments
5.18 Abcam
5.18.1 Abcam Profile
5.18.2 Abcam Main Business
5.18.3 Abcam G6PD Antibody Products, Services and Solutions
5.18.4 Abcam G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.18.5 Abcam Recent Developments
5.19 United States Biological
5.19.1 United States Biological Profile
5.19.2 United States Biological Main Business
5.19.3 United States Biological G6PD Antibody Products, Services and Solutions
5.19.4 United States Biological G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.19.5 United States Biological Recent Developments
5.20 Biobyt
5.20.1 Biobyt Profile
5.20.2 Biobyt Main Business
5.20.3 Biobyt G6PD Antibody Products, Services and Solutions
5.20.4 Biobyt G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.20.5 Biobyt Recent Developments
5.21 Jingjie PTM BioLab
5.21.1 Jingjie PTM BioLab Profile
5.21.2 Jingjie PTM BioLab Main Business
5.21.3 Jingjie PTM BioLab G6PD Antibody Products, Services and Solutions
5.21.4 Jingjie PTM BioLab G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.21.5 Jingjie PTM BioLab Recent Developments
5.22 Wuhan Fine
5.22.1 Wuhan Fine Profile
5.22.2 Wuhan Fine Main Business
5.22.3 Wuhan Fine G6PD Antibody Products, Services and Solutions
5.22.4 Wuhan Fine G6PD Antibody Revenue (US$ Million) & (2018-2023)
5.22.5 Wuhan Fine Recent Developments
6 North America
6.1 North America G6PD Antibody Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe G6PD Antibody Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific G6PD Antibody Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America G6PD Antibody Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa G6PD Antibody Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 G6PD Antibody Market Dynamics
11.1 G6PD Antibody Industry Trends
11.2 G6PD Antibody Market Drivers
11.3 G6PD Antibody Market Challenges
11.4 G6PD Antibody Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market G6PD Antibody Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global G6PD Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global G6PD Antibody Market Size Share by Region (2018-2023)
Table 4. Global G6PD Antibody Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global G6PD Antibody Forecasted Market Size Share by Region (2024-2033)
Table 6. Global G6PD Antibody Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global G6PD Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global G6PD Antibody Revenue Market Share by Type (2018-2023)
Table 9. Global G6PD Antibody Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global G6PD Antibody Revenue Market Share by Type (2024-2033)
Table 11. North America G6PD Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America G6PD Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe G6PD Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe G6PD Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific G6PD Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific G6PD Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America G6PD Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America G6PD Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa G6PD Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa G6PD Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global G6PD Antibody Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global G6PD Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global G6PD Antibody Revenue Market Share by Application (2018-2023)
Table 24. Global G6PD Antibody Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global G6PD Antibody Revenue Market Share by Application (2024-2033)
Table 26. North America G6PD Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America G6PD Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe G6PD Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe G6PD Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific G6PD Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific G6PD Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America G6PD Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America G6PD Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa G6PD Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa G6PD Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global G6PD Antibody Revenue (US$ Million) by Players (2018-2023)
Table 37. Global G6PD Antibody Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in G6PD Antibody as of 2022)
Table 39. Date of Key Players Enter into G6PD Antibody Market
Table 40. Global G6PD Antibody Key Players Headquarters and Area Served
Table 41. G6PD Antibody Product Solution and Service
Table 42. Global G6PD Antibody Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Merck Basic Information List
Table 45. Merck Description and Business Overview
Table 46. Merck G6PD Antibody Products, Services and Solutions
Table 47. Revenue (US$ Million) in G6PD Antibody Business of Merck (2018-2023)
Table 48. Merck Recent Developments
Table 49. IBL Basic Information List
Table 50. IBL Description and Business Overview
Table 51. IBL G6PD Antibody Products, Services and Solutions
Table 52. Revenue (US$ Million) in G6PD Antibody Business of IBL (2018-2023)
Table 53. IBL Recent Developments
Table 54. GeneTex Basic Information List
Table 55. GeneTex Description and Business Overview
Table 56. GeneTex G6PD Antibody Products, Services and Solutions
Table 57. Revenue (US$ Million) in G6PD Antibody Business of GeneTex (2018-2023)
Table 58. GeneTex Recent Developments
Table 59. Aviva Systems Biology Basic Information List
Table 60. Aviva Systems Biology Description and Business Overview
Table 61. Aviva Systems Biology G6PD Antibody Products, Services and Solutions
Table 62. Revenue (US$ Million) in G6PD Antibody Business of Aviva Systems Biology (2018-2023)
Table 63. Aviva Systems Biology Recent Developments
Table 64. LifeSpan BioSciences Basic Information List
Table 65. LifeSpan BioSciences Description and Business Overview
Table 66. LifeSpan BioSciences G6PD Antibody Products, Services and Solutions
Table 67. Revenue (US$ Million) in G6PD Antibody Business of LifeSpan BioSciences (2018-2023)
Table 68. LifeSpan BioSciences Recent Developments
Table 69. RayBiotech Basic Information List
Table 70. RayBiotech Description and Business Overview
Table 71. RayBiotech G6PD Antibody Products, Services and Solutions
Table 72. Revenue (US$ Million) in G6PD Antibody Business of RayBiotech (2018-2023)
Table 73. RayBiotech Recent Developments
Table 74. NSJ Bioreagents Basic Information List
Table 75. NSJ Bioreagents Description and Business Overview
Table 76. NSJ Bioreagents G6PD Antibody Products, Services and Solutions
Table 77. Revenue (US$ Million) in G6PD Antibody Business of NSJ Bioreagents (2018-2023)
Table 78. NSJ Bioreagents Recent Developments
Table 79. ProSci Basic Information List
Table 80. ProSci Description and Business Overview
Table 81. ProSci G6PD Antibody Products, Services and Solutions
Table 82. Revenue (US$ Million) in G6PD Antibody Business of ProSci (2018-2023)
Table 83. ProSci Recent Developments
Table 84. Abnova Corporation Basic Information List
Table 85. Abnova Corporation Description and Business Overview
Table 86. Abnova Corporation G6PD Antibody Products, Services and Solutions
Table 87. Revenue (US$ Million) in G6PD Antibody Business of Abnova Corporation (2018-2023)
Table 88. Abnova Corporation Recent Developments
Table 89. Bethyl Laboratories Basic Information List
Table 90. Bethyl Laboratories Description and Business Overview
Table 91. Bethyl Laboratories G6PD Antibody Products, Services and Solutions
Table 92. Revenue (US$ Million) in G6PD Antibody Business of Bethyl Laboratories (2018-2023)
Table 93. Bethyl Laboratories Recent Developments
Table 94. Cell Signaling Technology Basic Information List
Table 95. Cell Signaling Technology Description and Business Overview
Table 96. Cell Signaling Technology G6PD Antibody Products, Services and Solutions
Table 97. Revenue (US$ Million) in G6PD Antibody Business of Cell Signaling Technology (2018-2023)
Table 98. Cell Signaling Technology Recent Developments
Table 99. Leading Biology Basic Information List
Table 100. Leading Biology Description and Business Overview
Table 101. Leading Biology G6PD Antibody Products, Services and Solutions
Table 102. Revenue (US$ Million) in G6PD Antibody Business of Leading Biology (2018-2023)
Table 103. Leading Biology Recent Developments
Table 104. Thermo Fisher Scientific Basic Information List
Table 105. Thermo Fisher Scientific Description and Business Overview
Table 106. Thermo Fisher Scientific G6PD Antibody Products, Services and Solutions
Table 107. Revenue (US$ Million) in G6PD Antibody Business of Thermo Fisher Scientific (2018-2023)
Table 108. Thermo Fisher Scientific Recent Developments
Table 109. OriGene Technologies Basic Information List
Table 110. OriGene Technologies Description and Business Overview
Table 111. OriGene Technologies G6PD Antibody Products, Services and Solutions
Table 112. Revenue (US$ Million) in G6PD Antibody Business of OriGene Technologies (2018-2023)
Table 113. OriGene Technologies Recent Developments
Table 114. ABclonal Technology Basic Information List
Table 115. ABclonal Technology Description and Business Overview
Table 116. ABclonal Technology G6PD Antibody Products, Services and Solutions
Table 117. Revenue (US$ Million) in G6PD Antibody Business of ABclonal Technology (2018-2023)
Table 118. ABclonal Technology Recent Developments
Table 119. Proteintech Group Basic Information List
Table 120. Proteintech Group Description and Business Overview
Table 121. Proteintech Group G6PD Antibody Products, Services and Solutions
Table 122. Revenue (US$ Million) in G6PD Antibody Business of Proteintech Group (2018-2023)
Table 123. Proteintech Group Recent Developments
Table 124. Sino Biological Basic Information List
Table 125. Sino Biological Description and Business Overview
Table 126. Sino Biological G6PD Antibody Products, Services and Solutions
Table 127. Revenue (US$ Million) in G6PD Antibody Business of Sino Biological (2018-2023)
Table 128. Sino Biological Recent Developments
Table 129. Abcam Basic Information List
Table 130. Abcam Description and Business Overview
Table 131. Abcam G6PD Antibody Products, Services and Solutions
Table 132. Revenue (US$ Million) in G6PD Antibody Business of Abcam (2018-2023)
Table 133. Abcam Recent Developments
Table 134. United States Biological Basic Information List
Table 135. United States Biological Description and Business Overview
Table 136. United States Biological G6PD Antibody Products, Services and Solutions
Table 137. Revenue (US$ Million) in G6PD Antibody Business of United States Biological (2018-2023)
Table 138. United States Biological Recent Developments
Table 139. Biobyt Basic Information List
Table 140. Biobyt Description and Business Overview
Table 141. Biobyt G6PD Antibody Products, Services and Solutions
Table 142. Revenue (US$ Million) in G6PD Antibody Business of Biobyt (2018-2023)
Table 143. Biobyt Recent Developments
Table 144. Jingjie PTM BioLab Basic Information List
Table 145. Jingjie PTM BioLab Description and Business Overview
Table 146. Jingjie PTM BioLab G6PD Antibody Products, Services and Solutions
Table 147. Revenue (US$ Million) in G6PD Antibody Business of Jingjie PTM BioLab (2018-2023)
Table 148. Jingjie PTM BioLab Recent Developments
Table 149. Wuhan Fine Basic Information List
Table 150. Wuhan Fine Description and Business Overview
Table 151. Wuhan Fine G6PD Antibody Products, Services and Solutions
Table 152. Revenue (US$ Million) in G6PD Antibody Business of Wuhan Fine (2018-2023)
Table 153. Wuhan Fine Recent Developments
Table 154. North America G6PD Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 155. North America G6PD Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 156. Europe G6PD Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 157. Europe G6PD Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 158. Asia-Pacific G6PD Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 159. Asia-Pacific G6PD Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 160. Asia-Pacific G6PD Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 161. Asia-Pacific G6PD Antibody Market Share by Region (2018-2023)
Table 162. Asia-Pacific G6PD Antibody Market Share by Region (2024-2033)
Table 163. Latin America G6PD Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 164. Latin America G6PD Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 165. Latin America G6PD Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 166. Middle East & Africa G6PD Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 167. Middle East & Africa G6PD Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 168. Middle East & Africa G6PD Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 169. G6PD Antibody Market Trends
Table 170. G6PD Antibody Market Drivers
Table 171. G6PD Antibody Market Challenges
Table 172. G6PD Antibody Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global G6PD Antibody Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global G6PD Antibody Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global G6PD Antibody Market Share by Regions: 2022 VS 2033
Figure 4. Global G6PD Antibody Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America G6PD Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe G6PD Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific G6PD Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America G6PD Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa G6PD Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Monoclonal
Figure 11. Global Monoclonal Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Polyclonal
Figure 13. Global Polyclonal Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global G6PD Antibody Market Size Share by Type: 2022 & 2033
Figure 15. North America G6PD Antibody Revenue Market Share by Type (2018-2033)
Figure 16. Europe G6PD Antibody Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific G6PD Antibody Revenue Market Share by Type (2018-2033)
Figure 18. Latin America G6PD Antibody Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa G6PD Antibody Revenue Market Share by Type (2018-2033)
Figure 20. Immunochemistry (IHC) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Immunofluorescence (IF) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Immunoprecipitation (IP) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Western Blot (WB) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. ELISA Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Global G6PD Antibody Market Size Share by Application: 2022 & 2033
Figure 27. North America G6PD Antibody Revenue Market Share by Application (2018-2033)
Figure 28. Europe G6PD Antibody Revenue Market Share by Application (2018-2033)
Figure 29. Asia-Pacific G6PD Antibody Revenue Market Share by Application (2018-2033)
Figure 30. Latin America G6PD Antibody Revenue Market Share by Application (2018-2033)
Figure 31. Middle East and Africa G6PD Antibody Revenue Market Share by Application (2018-2033)
Figure 32. G6PD Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players G6PD Antibody Market Share in 2022
Figure 34. North America G6PD Antibody Market Share by Country (2018-2033)
Figure 35. United States G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 36. Canada G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 37. Germany G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 38. France G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 39. U.K. G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 40. Italy G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 41. Russia G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 42. Nordic Countries G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 43. Asia-Pacific G6PD Antibody Market Share by Region (2018-2033)
Figure 44. China G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 45. Japan G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 46. South Korea G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 47. Southeast Asia G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 48. India G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 49. Australia G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 50. Latin America G6PD Antibody Market Share by Country (2018-2033)
Figure 51. Mexico G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 52. Brazil G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 53. Middle East & Africa G6PD Antibody Market Share by Country (2018-2033)
Figure 54. Turkey G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 56. UAE G6PD Antibody Market Size (2018-2033) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report